- Home
- III vs TRDA Comparison
III vs TRDA Comparison
Compare III & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- III
- TRDA
- Stock Information
- Founded
- III 2006
- TRDA 2016
- Country
- III United States
- TRDA United States
- Employees
- III N/A
- TRDA 183
- Industry
- III Professional Services
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- III Consumer Discretionary
- TRDA Health Care
- Exchange
- III Nasdaq
- TRDA Nasdaq
- Market Cap
- III 227.5M
- TRDA 264.5M
- IPO Year
- III 2007
- TRDA 2021
- Fundamental
- Price
- III $4.81
- TRDA $6.71
- Analyst Decision
- III Buy
- TRDA Strong Buy
- Analyst Count
- III 1
- TRDA 3
- Target Price
- III $5.50
- TRDA $25.67
- AVG Volume (30 Days)
- III 227.1K
- TRDA 144.8K
- Earning Date
- III 08-06-2025
- TRDA 08-12-2025
- Dividend Yield
- III 3.72%
- TRDA N/A
- EPS Growth
- III N/A
- TRDA N/A
- EPS
- III 0.16
- TRDA 0.61
- Revenue
- III $242,899,000.00
- TRDA $172,220,000.00
- Revenue This Year
- III N/A
- TRDA N/A
- Revenue Next Year
- III $5.08
- TRDA N/A
- P/E Ratio
- III $30.91
- TRDA $10.77
- Revenue Growth
- III N/A
- TRDA 5.74
- 52 Week Low
- III $2.95
- TRDA $6.49
- 52 Week High
- III $5.28
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- III 50.05
- TRDA 49.92
- Support Level
- III $4.98
- TRDA $6.87
- Resistance Level
- III $5.28
- TRDA $7.62
- Average True Range (ATR)
- III 0.17
- TRDA 0.30
- MACD
- III 0.00
- TRDA 0.08
- Stochastic Oscillator
- III 37.33
- TRDA 82.04
About III Information Services Group Inc.
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.